Delray Beach, FL, Jan. 20, 2025 (GLOBE NEWSWIRE) — The global AI in oncology market, valued at US$1.92 billion in 2023, is forecasted to grow at a robust CAGR of 29.4%, reaching US$2.45 billion in 2024 and an impressive US$11.52 billion by 2030. The growth is attributed to the increasing healthcare expenditures, rising adoption of advanced healthcare infrastructure worldwide, growing prevalence of solid tumors and blood cancers globally and the adoption of AI for such cancer’s early detection and prevention. In addition, the growing regulatory approvals for AI based software and tools and further its incorporation with radiographic imaging to enhance breast cancer diagnosis is the key factors driving market growth. For instance, in November 2022, Google Health partnered with iCAD to showcase its AI model for…